# K090187: Fora G30 Blood Glucose Monitoring System, Model TD-4241

- Pathway: 510(k) (Traditional)
- Applicant: Taidoc Technology Corporation
- Decided: May 12, 2009 after 106 days
- Product code: NBW (System, Test, Blood Glucose, Over The Counter)
- Device class: 2
- Regulation: 21 CFR 862.1345
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K070472 (2007). 1 ancestor in all.
26 later devices descend from it; 8 cite it directly.
0 of 28 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K070472: Clever Chek TD-4230 Blood Glucose Monitoring System, RD-4230, Surechek Blood Glucose Monitoring System, SMS-4230, Taidoc Technology Corporation (2007) Summary page 1.

## Most influential descendants
- K094005: Fora G31A/TD-4256A  Blood Glucose Monitoring System and Fora G31B/TD-4256B Blood Glucose Monitoring System (2010), 11 descendants of its own
- K101509: U-Right TD-4279 Blood Glucose Monitoring System, Fora GD40/TD-4272  Blood Glucose Monitoring System (2011), 6 descendants of its own
- K100322: TD-4277 Blood Glucose Monitoring System, Model 4277 (2010), 6 descendants of its own
- K101635: TD-4239 Blood Glucose Monitoring System  and TD-4239 Multi Blood Glucose Monitoring System (2011), 3 descendants of its own
- K190579: TD-4183 Blood Glucose Monitoring System (2019), 1 descendant of its own

## Indications for use
The FORA G30 Blood glucose monitoring system is intended for use in the quantitative measurement of glucose in fresh capillary whole blood from the finger and the following alternative sites: the palm, the forearm, the upper-arm, the calf and the thigh. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and is not intended for use on neonates. The alternative site testing in the FORA G30 Blood glucose monitoring system can be used only during steady-state blood glucose conditions.

Source page: https://510kreport.com/device/K090187
Methodology: https://510kreport.com/methodology